Drug Company Set to Pay $15 Million to DOJ Over Doctor Bribery Scandal
Two whistleblowers came forward in April to accuse Questcor of trying to boost profits for Acthar, a medication primarily for infants with seizures. Questcor raised the price of the medication by almost 100,000 percent (not a typo) from just $40 in 2000 to $38,892 today, despite the fact that Acthar has been on the market… Read More »